GOP Lawmakers Rip FDA's Generic-Drug Labeling Overhaul
Congressional Republicans on Wednesday sharply criticized the U.S. Food and Drug Administration's controversial plan to let generic-drug makers independently change their warning labels, saying they have "grave concerns" that the move...To view the full article, register now.
Already a subscriber? Click here to view full article